On January 24, 2020, Equidebt LLC announced that it has had and may continue to have discussions with other shareholders of Zomedica Pharmaceuticals Corp. and may have discussions with the Company’s management and board of directors, potential acquirers and financing sources and other third parties relating to the Company’s business, operations, strategy, strategic alternatives for and relative valuations of the Company, including, but not limited to, in relation to the sale of its business or some or all of its assets, capital structure and capital raising alternatives, governance, current and future board and management team composition, future plans and related matters.